Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Fishman

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Journal of Substance Abuse Treatment|June 12, 2021
Drug and sexual HIV-risk behaviors among adolescents and young adults with opioid use disorderAriel Ludwig, Laura B Monico, Jan Gryczynski, et al.
Journal of Marital and Family Therapy|March 24, 2021
Conceptual framework for telehealth strategies to increase family involvement in treatment and recovery for youth opioid use disorderAaron Hogue, Molly Bobek, Sharon Levy, et al.
Psychiatric Services (Washington, D.C.)|June 20, 2023
Impact of Medication-Based Treatment on Health Care Utilization Among Individuals With Opioid Use DisorderManesh Gopaldas, Kevin Wenzel, Aimee N C Campbell, et al.
Journal of Substance Use and Addiction Treatment|March 17, 2024
Engagement, initiation, and retention in medication treatment for opioid use disorder among young adults: A narrative review of challenges and opportunitiesMarc Fishman, Kevin Wenzel, Phoebe Gauthier, et al.
The American Journal on Addictions|June 17, 2023
A pilot test of Written Exposure Therapy for PTSD in residential substance use treatmentRebecca L Schacht, Kevin R Wenzel, Laurel E Meyer, et al.
Psychiatric Services (Washington, D.C.)|April 12, 2023
Guidance for Handling the Increasing Prevalence of Drugs Adulterated or Laced With FentanylCraig Allen, Christina Arredondo, Rochelle Dunham, et al.
Substance Use & Addiction Journal|May 8, 2024
Stress Exposure and PTSD in a Cross-Sectional Residential Substance Use Treatment SampleRebecca L Schacht, Laurel E Meyer, Kevin R Wenzel, et al.
Drug and Alcohol Dependence|September 8, 2022
Buprenorphine & methadone dosing strategies to reduce risk of relapse in the treatment of opioid use disorderKara E Rudolph, Nicholas T Williams, Alicia T Singham Goodwin, et al.
Contemporary Clinical Trials|October 1, 2016
Ethical and clinical safety considerations in the design of an effectiveness trial: A comparison of buprenorphine versus naltrexone treatment for opioid dependenceEdward V Nunes, Joshua D Lee, Dominic Sisti, et al.
Substance Use & Misuse|April 3, 2026
Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X:BOT TrialKenzie Potter, Miranda Greiner, Matisyahu Shulman, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Journal of Substance Abuse Treatment|June 12, 2021
Drug and sexual HIV-risk behaviors among adolescents and young adults with opioid use disorderAriel Ludwig, Laura B Monico, Jan Gryczynski, et al.
Journal of Marital and Family Therapy|March 24, 2021
Conceptual framework for telehealth strategies to increase family involvement in treatment and recovery for youth opioid use disorderAaron Hogue, Molly Bobek, Sharon Levy, et al.
Psychiatric Services (Washington, D.C.)|June 20, 2023
Impact of Medication-Based Treatment on Health Care Utilization Among Individuals With Opioid Use DisorderManesh Gopaldas, Kevin Wenzel, Aimee N C Campbell, et al.
Journal of Substance Use and Addiction Treatment|March 17, 2024
Engagement, initiation, and retention in medication treatment for opioid use disorder among young adults: A narrative review of challenges and opportunitiesMarc Fishman, Kevin Wenzel, Phoebe Gauthier, et al.
The American Journal on Addictions|June 17, 2023
A pilot test of Written Exposure Therapy for PTSD in residential substance use treatmentRebecca L Schacht, Kevin R Wenzel, Laurel E Meyer, et al.
Psychiatric Services (Washington, D.C.)|April 12, 2023
Guidance for Handling the Increasing Prevalence of Drugs Adulterated or Laced With FentanylCraig Allen, Christina Arredondo, Rochelle Dunham, et al.
Substance Use & Addiction Journal|May 8, 2024
Stress Exposure and PTSD in a Cross-Sectional Residential Substance Use Treatment SampleRebecca L Schacht, Laurel E Meyer, Kevin R Wenzel, et al.
Drug and Alcohol Dependence|September 8, 2022
Buprenorphine & methadone dosing strategies to reduce risk of relapse in the treatment of opioid use disorderKara E Rudolph, Nicholas T Williams, Alicia T Singham Goodwin, et al.
Contemporary Clinical Trials|October 1, 2016
Ethical and clinical safety considerations in the design of an effectiveness trial: A comparison of buprenorphine versus naltrexone treatment for opioid dependenceEdward V Nunes, Joshua D Lee, Dominic Sisti, et al.
Substance Use & Misuse|April 3, 2026
Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X:BOT TrialKenzie Potter, Miranda Greiner, Matisyahu Shulman, et al.
Pageof 8